Form 4: Tarsus Pharmaceuticals Executive Sells Shares to Cover Tax Obligations

Aziz Mottiwala, Chief Commercial Officer of Tarsus Pharmaceuticals, sold shares of common stock to cover tax withholding obligations related to the vesting of Restricted Stock Units.

Summary

• On March 18, 2025, Aziz Mottiwala, the Chief Commercial Officer of Tarsus Pharmaceuticals, sold 3,643 shares of common stock at a price of $46.29.
• On March 19, 2025, Mottiwala sold 3,557 shares of common stock at a price of $47.4.
• On March 20, 2025, Mottiwala sold 3,365 shares of common stock at a price of $50.11.
• These sales were executed to cover tax withholding obligations associated with the vesting and settlement of Restricted Stock Units.
• Following these transactions, Mottiwala beneficially owns 65,057 shares of Tarsus Pharmaceuticals common stock.

Sentiment

Score: 5

Explanation: The document reflects routine transactions related to executive compensation and tax obligations, indicating a neutral sentiment.

Industry Context

Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among company executives.

Stakeholder Impact

• The sale of shares by the CCO could have a minor impact on shareholder sentiment, but is unlikely to be significant given the reason for the sale.

Key Dates

Keywords

Tarsus Pharmaceuticals, Aziz Mottiwala, Form 4, Share Sale, Tax Withholding, Restricted Stock Units, Beneficial Ownership, Officer, TARS